Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123673
Published online Jan 21, 2027. doi: 10.3748/wjg.123673
Published online Jan 21, 2027. doi: 10.3748/wjg.123673
Figure 3 METTL1 regulates PKM2 expression by targeting N7-methylguanosine modification of PKM mRNA.
A: Western blot verification of METTL1 knockdown efficiency in PANC-1 cells; B: Distribution characteristics and sequence conservation of N7-methylguanosine (m7G) modification peaks on PKM mRNA before and after METTL1 knockdown via m7G-methylated RNA immunoprecipitation (MeRIP)-sequencing; C: MeRIP-quantitative polymerase chain reaction quantification of m7G modification enrichment of PKM mRNA upon METTL1 overexpression; D and E: Fluorescence imaging and biotin-labeled probe pull-down assay verifying direct binding between METTL1 and PKM mRNA; F: Changes of m7G level and PKM2 expression after METTL1 intervention detected by Dot blot and western blot; G: Western blot analysis of epithelial-mesenchymal transition biomarker expression regulated by METTL1-PKM2 axis. bP < 0.01. m7G: N7-methylguanosine; PCR: Polymerase chain reaction; IgG: Immunoglobulin G.
- Citation: Yang C, Qiu CZ, Yin ZG, Mao Y, Ge XS, Wang F. METTL1-mediated N7-methylguanosine modification promotes glycolysis and H4K5 lactylation-dependent Snail-1 activation in pancreatic adenocarcinoma peritoneal metastasis. World J Gastroenterol 2027; 33(3): 123673
- URL: https://www.wjgnet.com/1007-9327/full/v33/i3/123673.htm
- DOI: https://dx.doi.org/10.3748/wjg.123673